Early diet and the risk of coeliac disease. An update 2024 position paper by the ESPGHAN special interest group on coeliac disease.
Autor: | Szajewska H; Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland., Shamir R; Institute of Gastroenterology, Nutrition and Liver Disease, Schneider Children's Medical Center of Israel, School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel., Auricchio R; Department of Translational Medical Sciences and European Laboratory for the Investigation of Food Induced Diseases, University Federico II, Naples, Italy., Chmielewska A; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden., Dolinsek J; Department of Pediatrics, University Medical Center Maribor, Maribor, Slovenia., Kivelä L; Celiac Disease Research Center, Tampere University, Tampere, Finland.; Department of Pediatrics, Tampere University Hospital, Tampere, Finland.; Children's Hospital, Helsinki University Hospital, Helsinki, Finland.; Department of Paediatric Research, Faculty of Medicine, University of Oslo, Oslo, Norway., Koletzko S; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Munich, Germany.; Department of Pediatrics, School of Medicine Collegium Medicum, Gastroenterology and Nutrition, University of Warmia and Mazury, Olsztyn, Poland., Korponay-Szabo IR; Celiac Disease Center, Heim Pál National Paediatric Institute, Budapest, Hungary.; Department of Paediatrics, University of Debrecen, Debrecen, Hungary., Af Segerstad EMH; Department of Pediatric Research, Oslo University Hospital, Oslo, Norway.; Unit of Celiac and Diabetes Research, Clinical Sciences Malmö, Lund university, Lund, Sweden.; Department of Pediatrics, Skane University Hospital, Malmö, Sweden., Mearin ML; Department of Paediatric Gastroenterology, Leiden University Medical Center - Willem Alexander Children's Hospital, Leiden, The Netherlands., Meijer-Boekel C; Department of Paediatric Gastroenterology, Leiden University Medical Center - Willem Alexander Children's Hospital, Leiden, The Netherlands., Konickx CR; Pediatric Gastroenterology, La Fe University Hospital, Instituto de Investigation Sanitaria La FE Valencia, Valencia, Spain., Rodriguez-Herrera A; St Luke's General Hospital, University College Dublin, Dublin, Ireland., Stordal K; Department of Paediatric Research, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Paediatric and Adolescent Medicine, Oslo University Hospital, Oslo, Norway., Troncone R; Department of Translational Medical Sciences and European Laboratory for the Investigation of Food Induced Diseases, University Federico II, Naples, Italy., Wessels M; Department of Paediatrics, Rijnstate Hospital, Arnhem, The Netherlands. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of pediatric gastroenterology and nutrition [J Pediatr Gastroenterol Nutr] 2024 Aug; Vol. 79 (2), pp. 438-445. Date of Electronic Publication: 2024 Jun 07. |
DOI: | 10.1002/jpn3.12280 |
Abstrakt: | This position paper by the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) Special Interest Group on Coeliac Disease (SIG-CD) presents an update to the 2016 recommendations concerning early diet and the risk of coeliac disease (CD). This update adheres to the policy that mandates reviewing guidelines every 5 years, particularly when new data emerge. The 2024 statements and recommendations are essentially similar to the 2016 recommendations. Breastfeeding, whether any amount, exclusive, or of any duration, does not reduce the risk of developing CD. Introducing gluten into an infant's diet at any time between completed 4 months (≥17 weeks) and 12 months of age does not affect the cumulative incidence of CD, although earlier introduction may lead to earlier seroconversion and CD. In observational studies involving cohorts with a known risk for CD, consuming a high amount of gluten compared to a low amount during weaning and in the subsequent childhood years-specifically the first 2-3 years, and even up to 5 years in some studies-was associated with an increased risk for CD. However, the specific optimal amounts of gluten consumption remain undetermined due to insufficient evidence on safe thresholds, and the impact of restricting gluten in the diet of healthy children of unknown risk for CD is unknown. Thus, any recommendation on the gluten amount is currently unjustifiable for the general population and infants with known HLA risk types. There is no specific guidance on the type of gluten-containing foods to be introduced at weaning. (© 2024 European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.) |
Databáze: | MEDLINE |
Externí odkaz: |